Asia Will Become Strategic Imperative For Pharmaceutical Companies, Quintiles Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Pipeline pressures will make Asia a contributor to drug discovery and research innovation as well as a market and support powerhouse, the CRO says.